Canopy Growth Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Canopy Growth Corp (CGC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 2.84M shares, a 12.52% increase year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 13.94K shares.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 261.04K shares, a 5488.50% increase year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 2.80M shares, a 182.70% increase from fiscal 2025.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 990.11K shares, a 59.39% decline from fiscal 2024.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.44M shares, a 423.37% increase from fiscal 2023.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 465.88K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.84M shares 10-Q · filed 2026-08-07 | 2.84M shares derived: sum of 2 quarters · filed 2026-08-07 | 2.85M shares derived: sum of 3 quarters · filed 2026-08-07 | 3.11M shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | 13.94K shares derived: sum of 2 quarters · filed 2026-06-15 | 274.98K shares derived: sum of 3 quarters · filed 2026-06-15 | 2.80M shares 10-K · filed 2026-06-15 |
| 2025-12-31 | 13.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | 274.98K shares derived: sum of 2 quarters · filed 2026-02-06 | 2.80M shares 10-Q · filed 2026-02-06 | 3.02M shares derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-09-30 | 261.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-07 | 2.79M shares 10-Q · filed 2025-11-07 | 3.01M shares derived: sum of 3 quarters · filed 2026-06-15 | 3.01M shares derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-06-30 | 2.52M shares 10-Q · filed 2025-08-08 | 2.75M shares derived: sum of 2 quarters · filed 2026-06-15 | 2.75M shares derived: sum of 3 quarters · filed 2026-06-15 | 2.75M shares derived: sum of 4 quarters · filed 2026-06-15 |
| 2025-03-31 | 225.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | 225.00K shares derived: sum of 2 quarters · filed 2026-06-15 | 229.67K shares derived: sum of 3 quarters · filed 2026-06-15 | 990.11K shares 10-K · filed 2026-06-15 |
| 2024-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | 4.67K shares derived: sum of 2 quarters · filed 2025-02-07 | 765.11K shares 10-Q · filed 2025-02-07 | 765.11K shares derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-09-30 | 4.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | 765.11K shares 10-Q · filed 2024-11-08 | 765.11K shares derived: sum of 3 quarters · filed 2026-06-15 | -20.84M shares derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-06-30 | 760.44K shares 10-Q · filed 2024-08-09 | 760.44K shares derived: sum of 2 quarters · filed 2026-06-15 | -20.84M shares derived: sum of 3 quarters · filed 2026-06-15 | -20.84M shares derived: sum of 4 quarters · filed 2026-06-15 |
| 2024-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-15 | -21.60M shares derived: sum of 2 quarters · filed 2026-06-15 | -21.60M shares derived: sum of 3 quarters · filed 2026-06-15 | 2.44M shares 10-K · filed 2026-06-15 |
| 2023-12-31 | -21.60M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-09 | -21.60M shares derived: sum of 2 quarters · filed 2024-02-09 | 2.44M shares 10-Q · filed 2024-02-09 | -1.75M shares derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09 | 24.04M shares 10-Q · filed 2023-11-09 | 19.85M shares derived: sum of 3 quarters · filed 2025-05-30 | 21.15M shares derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-06-30 | 24.04M shares 10-Q · filed 2023-08-09 | 19.85M shares derived: sum of 2 quarters · filed 2025-05-30 | 21.15M shares derived: sum of 3 quarters · filed 2025-05-30 | 21.41M shares derived: sum of 4 quarters · filed 2025-05-30 |
| 2023-03-31 | -4.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-30 | -2.89M shares derived: sum of 2 quarters · filed 2025-05-30 | -2.63M shares derived: sum of 3 quarters · filed 2025-05-30 | 465.88K shares 10-K · filed 2025-05-30 |
| 2022-12-31 | 1.30M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 1.56M shares derived: sum of 2 quarters · filed 2023-02-09 | 4.65M shares 10-Q · filed 2023-02-09 | |
| 2022-09-30 | 262.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | 3.35M shares 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | 3.09M shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |